title: First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
abstract: We describe the first use of transradial access renal denervation in a patient with resistant hypertension using a dedicated radiofrequency catheter (Iberis™; Terumo Medical Corporation, Tokyo, Japan). The system includes a generator and a 4 Fr single-use radiofrequency (RF) device which has to be introduced via a 6 Fr guiding catheter. Radiofrequency energy is delivered at the tip of the catheter. The system was CE approved in March 2013.
authors.affiliation: Cardiovascular Unit of the Clinique Pasteur, Toulouse, France.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Honton
authors.forename: Atul
authors.initials: A
authors.lastname: Pathak
authors.forename: Antoine
authors.initials: A
authors.lastname: Sauguet
authors.forename: Jean
authors.initials: J
authors.lastname: Fajadet
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D017115:Catheter Ablation / Q000295:instrumentation / Q000379:methods; D004351:Drug Resistance; D004867:Equipment Design; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D007668:Kidney / Q000098:blood supply*; D008297:Male; D017534:Radial Artery / Q000000981:diagnostic imaging; D015641:Radiography, Interventional; D012077:Renal Artery / Q000000981:diagnostic imaging / Q000294:innervation*; D013562:Sympathectomy / Q000295:instrumentation / Q000379:methods; D016896:Treatment Outcome; D062666:Vascular Access Devices
chemical_list: D000959:Antihypertensive Agents